Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva

by | Jun 29, 2026 | Clinical Trials | 0 comments

​ Conditions: Vulvar Carcinoma; Recurrent or Metastatic Vulvar Cancer; Squamous Cell Carcinoma Vulva

Interventions: Drug: Tisotumab Vedotin

Sponsors: GOG Foundation; Pfizer

Not yet recruiting Conditions: Vulvar Carcinoma; Recurrent or Metastatic Vulvar Cancer; Squamous Cell Carcinoma Vulva
Interventions: Drug: Tisotumab Vedotin
Sponsors: GOG Foundation; Pfizer
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *